ArticleCancers2026

Survival and Safety Outcomes of Three-Cycle Adjuvant Chemotherapy in Intermediate-Risk Endometrial Cancer.

Shota Higami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.